Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Philip

Showing results (431-440 of 521) with videos related to

Pageof 53
Sort By:
Investigational New Drugs|January 29, 2010
A phase II study of isoflavones, erlotinib, and gemcitabine in advanced pancreatic cancerBassel Fuad El-Rayes, Philip A Philip, Fazlul H Sarkar, et al.
Gastrointestinal Cancer Research : GCR|November 1, 2012
A phase 2 trial of ixabepilone plus cetuximab in first-line treatment of metastatic pancreatic cancerCaio M Rocha Lima, Edward H Lin, George P Kim, et al.
Journal of Korean Neurosurgical Society|September 5, 2023
Predictors of Outcome in Management of Paediatric Head Trauma in a Tertiary Healthcare Institution in North-Central NigeriaGyang Markus Bot, Danaan J Shilong, Jerry A Philip, et al.
Annals of Surgical Oncology|January 19, 2006
A multi-institutional phase II trial of preoperative full-dose gemcitabine and concurrent radiation for patients with potentially resectable pancreatic carcinomaMark S Talamonti, William Small, Mary F Mulcahy, et al.
Osteoarthritis and Cartilage|April 25, 2008
Absence of association of asporin polymorphisms and osteoarthritis susceptibility in US CaucasiansU Atif, A Philip, J Aponte, et al.
Investigational New Drugs|September 15, 2010
An international, multicenter phase II trial of bortezomib in patients with hepatocellular carcinomaGeorge P Kim, Michelle R Mahoney, Daniel Szydlo, et al.
The Oncologist|July 19, 2018
Impact of Patient Age on Molecular Alterations of Left-Sided Colorectal TumorsAlberto Puccini, Heinz-Josef Lenz, John L Marshall, et al.
Molecular Cancer Research : MCR|March 11, 2018
Landscape of Tumor Mutation Load, Mismatch Repair Deficiency, and PD-L1 Expression in a Large Patient Cohort of Gastrointestinal CancersMohamed E Salem, Alberto Puccini, Axel Grothey, et al.
Cancers|December 5, 2019
PAK4-NAMPT Dual Inhibition as a Novel Strategy for Therapy Resistant Pancreatic Neuroendocrine TumorsGabriel Mpilla, Amro Aboukameel, Irfana Muqbil, et al.
JAMA Oncology|January 21, 2021
Efficacy of Perioperative Chemotherapy for Resectable Pancreatic Adenocarcinoma: A Phase 2 Randomized Clinical TrialDavendra P S Sohal, Mai Duong, Syed A Ahmad, et al.
Pageof 53

Showing results (431-440 of 521) with videos related to

Sort By:
Pageof 53
Investigational New Drugs|January 29, 2010
A phase II study of isoflavones, erlotinib, and gemcitabine in advanced pancreatic cancerBassel Fuad El-Rayes, Philip A Philip, Fazlul H Sarkar, et al.
Gastrointestinal Cancer Research : GCR|November 1, 2012
A phase 2 trial of ixabepilone plus cetuximab in first-line treatment of metastatic pancreatic cancerCaio M Rocha Lima, Edward H Lin, George P Kim, et al.
Journal of Korean Neurosurgical Society|September 5, 2023
Predictors of Outcome in Management of Paediatric Head Trauma in a Tertiary Healthcare Institution in North-Central NigeriaGyang Markus Bot, Danaan J Shilong, Jerry A Philip, et al.
Annals of Surgical Oncology|January 19, 2006
A multi-institutional phase II trial of preoperative full-dose gemcitabine and concurrent radiation for patients with potentially resectable pancreatic carcinomaMark S Talamonti, William Small, Mary F Mulcahy, et al.
Osteoarthritis and Cartilage|April 25, 2008
Absence of association of asporin polymorphisms and osteoarthritis susceptibility in US CaucasiansU Atif, A Philip, J Aponte, et al.
Investigational New Drugs|September 15, 2010
An international, multicenter phase II trial of bortezomib in patients with hepatocellular carcinomaGeorge P Kim, Michelle R Mahoney, Daniel Szydlo, et al.
The Oncologist|July 19, 2018
Impact of Patient Age on Molecular Alterations of Left-Sided Colorectal TumorsAlberto Puccini, Heinz-Josef Lenz, John L Marshall, et al.
Molecular Cancer Research : MCR|March 11, 2018
Landscape of Tumor Mutation Load, Mismatch Repair Deficiency, and PD-L1 Expression in a Large Patient Cohort of Gastrointestinal CancersMohamed E Salem, Alberto Puccini, Axel Grothey, et al.
Cancers|December 5, 2019
PAK4-NAMPT Dual Inhibition as a Novel Strategy for Therapy Resistant Pancreatic Neuroendocrine TumorsGabriel Mpilla, Amro Aboukameel, Irfana Muqbil, et al.
JAMA Oncology|January 21, 2021
Efficacy of Perioperative Chemotherapy for Resectable Pancreatic Adenocarcinoma: A Phase 2 Randomized Clinical TrialDavendra P S Sohal, Mai Duong, Syed A Ahmad, et al.
Pageof 53